The use of calcium in the treatment of cardiac failure dates from 1907 when Lauder Brunton (1907) reported good results from the administration of calcium chloride. It had, of course, long been known that the cardiac muscle of a perfused heart rapidly lost the power of contraction in the absence of calcium.
Clark (1913) found that increase in the force of contraction followed the addition of calcium to the perfusing fluid, especially when the cardiac action had become weak. He attributed the poor contractility to an insufficient content of calcium in the ventricular muscle. For some time, however, calcium therapy in heart disease was not held in great esteem. Lauder Brunton used calcium chloride in doses of 5 to 10 grains every four hours, amounts which generally produced no appreciable increase of serum calcium. With the lactate, which had a greater vogue than the chloride, the effect was even less.
Presumably any action which calcium may have on the heart is due to its accumulation in the tissues of that organ, and this in turn depends on Loewi, in 1918, drew attention to the close relationship between the actions of calcium and digitalis on the heart, and went so far as to suggest that the main effect of the digitalis glucosides was obtained by sensitizing the heart muscle to calcium. This view was supported by Dani^lopolu (1922) who recommended the intravenous administration of small amounts of calcium salts as an adjuvant to digitalis therapy. Singer (1921) stated that in heart failure calcium given intravenously led to slowing of the rate and a temporary increase in the force of ventricular contraction.
Billigheimer (1924) found that digitalis and calcium in association were of great value in many forms of decompensation and arrhythmia. Nyiri and Dubois (1930) , while stating that calcium and digitalis are not essentially related in their pharmacological actions, recommend their combined use as a therapeutic measure.
Digitalis has proved its value in the treatment of patients with congestive cardiac failure. Nevertheless there are some patients who fail to react to digitalis therapy. The present work was undertaken primarily to determine whether the exhibition of calcium would be of benefit in that group. In the course of the research the opportunity was taken to determine the effect of calcium on various manifestations of cardiac disease.
Calcium gluconate in 10 per cent solution was injected intravenously in doses of 10 cc.: at least two minutes was allowed for the injection. This is of some importance, since a rapid rate of administration may lead to severe toxic manifestations (Lloyd, 1928 ; Liebermann, 1933) .
Effect of Calcium upon the Heart-Rate.
All previous investigators are agreed that intravenous injection of calcium salts leads to slowing of the heart-rate. Petzetakis (1924) In 26 patients with varying degrees of cardiac failure the heart-rate was determined by auscultation at the apex before and after the intravenous administration of calcium gluconate.
Any effect of the rate of injection was standardized by allowing in every case two to three minutes for the administration. Care was taken to minimize any preliminary excitement by accustoming the patient to all the routine of an intravenous injection. As a control, in some cases, intravenous sodium chloride was given, but without significant alteration of heartrate. The heart-rate was taken continuously from ten minutes before till five minutes after the conclusion of injection and at varying intervals thereafter.
Of the 26 patients investigated, it was found that 20 reacted to the calcium gluconate by a slowing of the heart-rate of from six to seventy-eight beats per minute; in the other 6 no change occurred. The time of maximal slowing varied from five minutes to more than twenty-four hours. The time relationship of the reduction of heart-rate in a typical case is shown in Fig. 1 ; it is evident that slowing did not proceed regularly.
In 5 of the 6 cases in which there was no appreciable change in the heart-rate there was auricular fibrillation. The maximum 149 another.
In patients with 'auricular fibrillation no such relationship could be established.
These findings would appear to throw some light on the locus of action of calcium. In most patients with regular rhythm all the heart-beats arise from the normal pacemaker, the sinoauricular node, which is largely under the influence of the vagus mechanism.
In patients with auricular fibrillation, however, (1910) found that the inhibitory effect of vagus stimulation disappeared in the absence of calcium. This was disputed by Brine (1917) who worked on the turtle heart. Brull (1924) found that calcium strengthened the contraction of the isolated heart of the dog. He (1920) , using rabbits and guinea-pigs, observed, following the injection of calcium salts, a deepening of S, disappearance of P, and flattening of T waves and widening of the QRS complex. Berliner (1933) noted in man an increase in the P wave and changes in the direction and amplitude of T. Segall and White (1925) studied the effect of oral administration of calcium in 11 patients, in 8 of whom they observed one or more of the following effects:?slowing of the heart, variations in the PR interval, increase in T and increase or decrease in P. Berliner (1936) A consideration of the results recorded in the literature and those obtained in the present investigation lead one to the conclusion that calcium may affect the heart in two ways:?
(1) indirectly through the vagal system, and (2) directly through the myocardium. The evidence of sinus slowing, the greater effectiveness of calcium in reducing the heart-rate in patients with regular rhythm and the abolition of the bradycardia effect by atropine all point to a vagal action. The changes in the T wave, the greater tendency to coupling, and the lengthening of diastole observed in the electrocardiograms indicate some direct action on the heart muscle. The fact that these findings are not so frequent as the sinus slowing would suggest that as a rule larger doses of calcium are required to produce the myocardial effect than to stimulate the vagus control.
Effect of Calcium upon Blood Pressure.
All writers agree that calcium slows the heart-rate, but there is not the same unanimity of opinion with regard to its effect on blood pressure.
Singer (1921) claimed that intravenous injection of calcium salts lowered the blood pressure. Brull (1924) , working on dogs, maintained that calcium raised the pressure as a result of peripheral vasoconstriction in association with a direct action on heart muscle.
Only when extreme bradycardia was produced did he find that the pressure was lowered. Edwards and Page (1926) In 18 patients the venous pressure was estimated by the method described by Lewis. In 11 the injection of calcium gluconate was followed by a slight fall varying from 025 to 2'0 cm.: in 7 instances there was no change, but in no case did the pressure rise. The slight reduction in venous pressure is probably to be attributed to improvement in heart action.
Effect of Calcium upon Respiration.
Hooker (1912) found that the addition of calcium to fluid perfusing a frog's brain stimulated the respiratory centre when potassium was also present. In patients with heart failure the dyspnoea is the result of circulatory defect. Accordingly if the injection of calcium gluconate increases the efficiency of the heart, the respiratory rate should be diminished. This point was investigated in 6 patients by means of a stethograph with a pointer writing on a smoked drum. In 5 of the 6 patients the rate was slightly reduced; in 3 the irregularity was diminished, and in 3 the amplitude decreased. The heart-rate varied round 90 per minute, and was regular in rhythm ; the sounds were faint. Digitalis was given without significant effect on symptoms or signs. This was stopped and intravenous injections of 20 per cent glucose in saline were given on 9th, 10th, and 11th February. These were followed by transient diminution of cyanosis without any effect on the dyspnoea. On 15th February, the patient's condition was as poor as it had been on admission. Intravenous injections of calcium gluconate were then commenced and given daily until 21st February.
Progressive relief of dyspnoea and diminution of cyanosis were noted. On 15th March, the patient was discharged, able to walk without undue dyspnoea. Although still breathless on exertion, he was able to do much more than had been possible for many months previously. Calcium was found to slow the heart-rate, the rhythm apparently playing an important part in the degree of slowing produced. When 
